Anticoagulation-associated Adverse Drug Events

Abstract

Purpose Anticoagulant drugs are among the most common medications that cause adverse drug events (ADEs) in hospitalized patients. We performed a five-year retrospective study at Brigham and Women’s Hospital to determine clinical characteristics, types, root causes, and outcomes of anticoagulant-associated adverse drug events (ADEs). Methods We reviewed all inpatient anticoagulant-associated ADEs, including adverse drug reactions (ADRs) and medication errors, reported at Brigham and Women’s Hospital through the Safety Reporting System from May 2004 to May 2009. We also collected data regarding the cost associated with hospitalizations in which ADRs occurred. Results Of 463 anticoagulant-associated ADEs, 226 were MEs (48.8%), 141 were ADRs (30.5%), and 96 (20.7%) involved both a medication error and ADR. Seventy percent of anticoagulant-associated ADEs were potentially preventable. Transcription errors (48%) were the most frequent root cause of anticoagulant-associated medication errors, while medication errors (40%) were a common root cause of anticoagulant-associated ADRs. Death within 30 days of anticoagulant-associated ADEs occurred in 11% of patients. After an anticoagulant-associated ADR, most hospitalization expenditures were attributable to nursing costs (mean $33,189 per ADR) followed by pharmacy costs (mean $7,451 per ADR). Conclusion Most anticoagulant-associated ADEs among inpatients result from medication errors and are therefore potentially preventable. We observed an elevated 30-day mortality rate among patients who suffered an anticoagulant-associated ADE and high hospitalization costs following ADRs. Further Quality Improvement efforts to reduce anticoagulant-associated medication errors are warranted to improve patient safety and decrease health care expenditures.

The effect of clinical supervision model on high alert medication safety in intensive care units nurses

“…[14] This study aimed to investigate the effect of computer recording of medical orders on the number of adverse medication events and errors, and was a two-group study with a control group and a higher number of subjects compared to the present study. In another study, the researchers reported positive results in investigation of the effect of interactional education on reduction of medication errors of high-risk drugs in ICUs.…”

Circulating Immune Complexes of IgA Bound to Beta 2 Glycoprotein are Strongly Associated with the Occurrence of Acute Thrombotic Events

“…The mainstay of the treatment is thromboprophylaxis, usually using Vitamin K antagonists. However, there is no consensus regarding the patient screening criteria and treatment duration because anticoagulant drugs are among the most common medications that cause adverse events 39) . Therefore, in order to select which patients should receive thromboprophylaxis, new biomarkers are needed that would make it possible to identify patients with a pro-thrombotic state and at high risk of clinical events 40) .…”

Anticoagulant therapy: we have to do better! A systematic review

“…Because the authors performed a root cause analysis, they were able to look at the reason why the errors occurred. The most common cause was transcription errors (48%), followed by memory lapses (16.1%) and infusion or parenteral administration problems (8.7%); this is despite the presence of a Medical Information System that integrates online medical records, computerised provider order entries and electronic medication administration records 13. Aside from articles about medication errors in hospital, Fanikos et al focused on adverse drug events and medication errors in hospitalised patients with cardiac issues 14.…”